Multiple Sclerosis, An Issue of Neurologic Clinics: The Clinics: Internal Medicine, cartea 42-1
Editat de Carrie M. Hershen Limba Engleză Hardback – 21 noi 2023
Din seria The Clinics: Internal Medicine
- 70% Preț: 171.46 lei
- 70% Preț: 185.63 lei
- 18% Preț: 348.02 lei
- 18% Preț: 472.21 lei
- 18% Preț: 472.51 lei
- 18% Preț: 447.45 lei
- 5% Preț: 518.61 lei
- 5% Preț: 518.65 lei
- 5% Preț: 518.94 lei
- 5% Preț: 519.41 lei
- 5% Preț: 517.94 lei
- 5% Preț: 519.58 lei
- 5% Preț: 573.58 lei
- 5% Preț: 403.10 lei
- 5% Preț: 402.75 lei
- 5% Preț: 403.02 lei
- 18% Preț: 243.97 lei
- 18% Preț: 334.91 lei
- 5% Preț: 402.94 lei
- 5% Preț: 463.34 lei
- 5% Preț: 460.59 lei
- 5% Preț: 403.42 lei
- 5% Preț: 405.51 lei
- 5% Preț: 402.75 lei
- 5% Preț: 460.68 lei
- 18% Preț: 399.26 lei
- 5% Preț: 460.15 lei
- 5% Preț: 506.69 lei
- 5% Preț: 448.58 lei
- 5% Preț: 402.06 lei
- 5% Preț: 402.50 lei
- 5% Preț: 402.50 lei
- 5% Preț: 519.13 lei
- 5% Preț: 518.36 lei
- 5% Preț: 601.65 lei
- 5% Preț: 518.19 lei
- 5% Preț: 518.07 lei
- 21% Preț: 447.44 lei
- 22% Preț: 446.08 lei
- 5% Preț: 576.42 lei
- 5% Preț: 576.15 lei
- 5% Preț: 577.90 lei
- 5% Preț: 576.92 lei
- 5% Preț: 576.09 lei
- 5% Preț: 570.05 lei
- 5% Preț: 686.21 lei
- 18% Preț: 472.50 lei
- 5% Preț: 713.58 lei
- 5% Preț: 576.26 lei
- 5% Preț: 579.19 lei
Preț: 579.37 lei
Preț vechi: 609.86 lei
-5% Nou
Puncte Express: 869
Preț estimativ în valută:
110.87€ • 116.64$ • 92.03£
110.87€ • 116.64$ • 92.03£
Carte disponibilă
Livrare economică 25 decembrie 24 - 08 ianuarie 25
Livrare express 10-14 decembrie pentru 44.36 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323939171
ISBN-10: 0323939171
Pagini: 240
Dimensiuni: 152 x 229 x 143 mm
Greutate: 0.7 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
ISBN-10: 0323939171
Pagini: 240
Dimensiuni: 152 x 229 x 143 mm
Greutate: 0.7 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
Cuprins
Multiple Sclerosis Diagnostic Delay and Misdiagnosis
Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis
Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA
Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for Treatment
Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders
Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies
Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion
Bruton's Tyrosine Kinase Inhibitors for Multiple Sclerosis Treatment: A New Frontier
Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis
Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis: What Is the Future of Multiple Sclerosis Treatment?
Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis
Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable
Clinical and Treatment Considerations for the Pediatric and Aging Patients with Multiple Sclerosis
Women's Health and Pregnancy in Multiple Sclerosis
Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved
Era of COVID-19 in Multiple Sclerosis Care
Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis
Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA
Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for Treatment
Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders
Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies
Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion
Bruton's Tyrosine Kinase Inhibitors for Multiple Sclerosis Treatment: A New Frontier
Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis
Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis: What Is the Future of Multiple Sclerosis Treatment?
Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis
Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable
Clinical and Treatment Considerations for the Pediatric and Aging Patients with Multiple Sclerosis
Women's Health and Pregnancy in Multiple Sclerosis
Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved
Era of COVID-19 in Multiple Sclerosis Care